# POSACONAZOLE
> **ANDA214476** · Abbreviated New Drug Application (Generic) · Sponsor: BIOCON PHARMA · Approved 2022-02-04
## Drug
- **FDA Application Number:** ANDA214476
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** POSACONAZOLE
- **Generic name:** POSACONAZOLE
- **Active ingredients:** POSACONAZOLE
- **Dosage form:** TABLET, DELAYED RELEASE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** BIOCON PHARMA
- **Manufacturer:** Biocon Phama Inc.
- **First approval:** 2022-02-04
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214476)
---
*MORVS · CC0 1.0*